Related Experiment Videos
New activated RAS2 mutations identified in Saccharomyces cerevisiae
B A Wilson1, M Khalil, F Tamanoi
1Department of Molecular Microbiology and Immunology, University of Missouri School of Medicine, Columbia 65212.
Oncogene
|December 1, 1993
Summary
New research identified six amino acid changes that activate the Saccharomyces cerevisiae RAS2 protein, offering insights into cancer-related RAS mutations and GTPase activating protein interactions.
Area of Science:
- Molecular Biology
- Biochemistry
- Genetics
Background:
- Activating mutations in RAS proto-oncogenes are implicated in numerous human cancers.
- RAS proteins bind guanosine triphosphate (GTP) and regulate cellular processes.
Purpose of the Study:
- To identify novel mutations that activate the Saccharomyces cerevisiae RAS2 protein.
- To investigate the structural basis of RAS protein activation and regulation by GTPase activating proteins (GAPs).
Main Methods:
- Generated 35 random mutations in the RAS2 gene.
- Screened for mutations resulting in a dominant reduction of glycogen accumulation.
- Sequenced and characterized identified RAS2 alleles.
Main Results:
- Discovered six novel amino acid substitutions that activate RAS2.
- Identified RAS2-P41S and RAS2-E99K alleles, which are unresponsive to GAPs, affecting loop 2 and helix 3.
- Found mutations E130K, S153F, A154T, and A157S near the guanine binding site, potentially affecting nucleotide binding.
Conclusions:
- These findings expand the understanding of RAS protein activation mechanisms.
- The study reveals that GAPs interact with a larger surface area of RAS than previously thought.
- Identified mutations provide new tools for studying RAS signaling pathways and their role in diseases like cancer.